Skip to main content

Table 2 Results of antibiotic susceptibility of the clinical P. aeruginosa isolate, CCASUP2 against the tested antimicrobial agents

From: In vivo evaluation of a recombinant N-acylhomoserine lactonase formulated in a hydrogel using a murine model infected with MDR Pseudomonas aeruginosa clinical isolate, CCASUP2

Antimicrobial agent Susceptibility to antimicrobial agent MIC (μg/ml)
Co-amoxiclav (AMC) R 512
Azithromycin (AZM) R 32
Cefotaxime (CTX) R 64
Ciprofloxacin (CIP) R 128
gentamicin (CN) R 64
Meropenem (MEM) S 2
Levofloxacin (LEV) R 32
Tobramycin (TOB) R 16
Aztreonam (ATM) R 16
  1. S Sensitive, I Intermediate resistance, R  resistant)